Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients?

Acta Oncol. 2006;45(5):625-6. doi: 10.1080/02841860600791509.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / secondary
  • Capecitabine
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Disease-Free Survival
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / therapeutic use
  • Foot*
  • Hand*
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Predictive Value of Tests
  • Retrospective Studies
  • Survival Rate
  • Syndrome
  • Treatment Outcome

Substances

  • Deoxycytidine
  • Capecitabine
  • Fluorouracil